Journal of Antimicrobial Chemotherapy · 2014 · 272 citations · 67 references
PharmacyHospital PharmacyPharmacy PracticeAntimicrobial ResistanceAntimicrobial StewardshipHospital AdministrationAntibiotic ResistanceAntimicrobial Resistance PolicyAntimicrobial Resistance PreventionAntimicrobial Use SurveillanceHealthcare-associated Infection PreventionHospital Antimicrobial StewardshipAntibiotic Stewardship In HospitalsAntimicrobial Stewardship EducationAntimicrobial Usage SurveillanceE-prescribingElectronic PrescribingHospital Antimicrobial UtilizationInpatient Antimicrobial StewardshipStewardship Implementation
OBJECTIVES: To report the extent and components of global efforts in antimicrobial stewardship (AMS) in hospitals. METHODS: An Internet-based survey comprising 43 questions was disseminated worldwide in 2012. RESULTS: Responses were received from 660 hospitals in 67 countries: Africa, 44; Asia, 50; Europe, 361; North America, 72; Oceania, 30; and South and Central America, 103. National AMS standards existed in 52% of countries, 4% were planning them and 58% had an AMS programme. The main barriers to implementing AMS programmes were perceived to be a lack of funding or personnel, a lack of information technology and prescriber opposition. In hospitals with an existing AMS programme, AMS rounds existed in 64%; 81% restricted antimicrobials (carbapenems, 74.3%; quinolones, 64%; and cephalosporins, 58%); and 85% reported antimicrobial usage, with 55% linking data to resistance rates and 49% linking data to infection rates. Only 20% had electronic prescribing for all patients. A total of 89% of programmes educated their medical, nursing and pharmacy staff on AMS. Of the hospitals, 38% had formally reviewed their AMS programme: reductions were reported by 96% of hospitals for inappropriate prescribing, 86% for broad-spectrum antibiotic use, 80% for expenditure, 71% for healthcare-acquired infections, 65% for length of stay or mortality and 58% for bacterial resistance. CONCLUSIONS: The worldwide development and implementation of AMS programmes varies considerably. Our results should inform and encourage the further evaluation of this with a view to promoting a worldwide stewardship framework. The prospective measurement of well-defined outcomes of the impact of these programmes remains a significant challenge.
67
Antibiotic resistance—the need for global solutions
Ramanan Laxminarayan, Adriano Dusé, Chand Wattal et al. · The Lancet Infectious Diseases · 2013 · 4.4K citations · Full text
Timothy H. Dellit, Robert C. Owens, John E. McGowan et al. · Clinical Infectious Diseases · 2006 · 3.4K citations · Full text
Kevin B. Wright · Journal of Computer-Mediated Communication · 2006 · 2.5K citations
Peter Zarb, B. Coignard, Jolanta Griskeviciene et al. · Eurosurveillance · 2012 · 782 citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +15